Home › Therapeutic areas › Respiratory › Cystic Fibrosis
Cystic Fibrosis (3 companies)
Companies with an active program in Cystic Fibrosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics | OphthalmologyRespiratory Rare | 1 | Phase 3 | $677M | 5 |
| SION | Sionna Therapeutics | Respiratory Rare | 5 | Phase 2 | $148M | 5 |
| VTVT | vTv Therapeutics | HematologyMetabolic+1 Rare | 1 | Phase 3 | $84.4M | 9 |
No companies match.